Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT00724386
First received: July 25, 2008
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)